Using botulinum toxin A to treat postherpetic itch
Arch Dermatol Res
.
2023 Dec;315(10):2971-2972.
doi: 10.1007/s00403-023-02726-y.
Epub 2023 Sep 25.
Authors
Jessica Mineroff
1
,
Laura N Uwakwe
1
2
,
Jacob Mojeski
1
2
,
Jared Jagdeo
3
4
Affiliations
1
Department of Dermatology, State University of New York, Downstate Health Sciences University, Brooklyn, NY, USA.
2
Dermatology Service, Veterans Affairs New York Harbor Healthcare System-Brooklyn Campus, Brooklyn, NY, USA.
3
Department of Dermatology, State University of New York, Downstate Health Sciences University, Brooklyn, NY, USA. jrjagdeo@gmail.com.
4
Dermatology Service, Veterans Affairs New York Harbor Healthcare System-Brooklyn Campus, Brooklyn, NY, USA. jrjagdeo@gmail.com.
PMID:
37747568
DOI:
10.1007/s00403-023-02726-y
No abstract available
MeSH terms
Botulinum Toxins, Type A* / therapeutic use
Humans
Neuralgia, Postherpetic*
Pruritus / drug therapy
Substances
Botulinum Toxins, Type A